Mingyan Xu

1.1k total citations
46 papers, 610 citations indexed

About

Mingyan Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Mingyan Xu has authored 46 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 20 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Mingyan Xu's work include Cancer Genomics and Diagnostics (16 papers), Genetic factors in colorectal cancer (9 papers) and Colorectal Cancer Treatments and Studies (5 papers). Mingyan Xu is often cited by papers focused on Cancer Genomics and Diagnostics (16 papers), Genetic factors in colorectal cancer (9 papers) and Colorectal Cancer Treatments and Studies (5 papers). Mingyan Xu collaborates with scholars based in China, United States and United Kingdom. Mingyan Xu's co-authors include Shifu Chen, Tanxiao Huang, Jia Gu, Yue Han, Yanqing Zhou, Xiaoling Deng, Yu‐Cai Fu, Xiaoqiong Zhou, Xiaoni Zhang and Songlin Shi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Gut.

In The Last Decade

Mingyan Xu

44 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingyan Xu China 11 288 168 120 88 85 46 610
Tanxiao Huang China 11 239 0.8× 179 1.1× 181 1.5× 126 1.4× 108 1.3× 33 597
Panagiotis G. Adamopoulos Greece 17 568 2.0× 235 1.4× 96 0.8× 43 0.5× 53 0.6× 60 1.1k
Biswajit Das United States 9 250 0.9× 152 0.9× 66 0.6× 59 0.7× 35 0.4× 22 483
Ying Tong China 20 425 1.5× 159 0.9× 124 1.0× 86 1.0× 42 0.5× 67 1.0k
Kanika Arora United States 16 381 1.3× 138 0.8× 78 0.7× 50 0.6× 47 0.6× 45 734
Miyuki Murata Japan 17 375 1.3× 96 0.6× 67 0.6× 76 0.9× 66 0.8× 58 799
Mark Horswill United States 13 452 1.6× 259 1.5× 115 1.0× 89 1.0× 30 0.4× 18 858
Dmitrii E. Polev Russia 12 335 1.2× 97 0.6× 86 0.7× 41 0.5× 29 0.3× 53 584
Shudai Lin China 16 428 1.5× 231 1.4× 77 0.6× 76 0.9× 26 0.3× 48 777

Countries citing papers authored by Mingyan Xu

Since Specialization
Citations

This map shows the geographic impact of Mingyan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingyan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingyan Xu more than expected).

Fields of papers citing papers by Mingyan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingyan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingyan Xu. The network helps show where Mingyan Xu may publish in the future.

Co-authorship network of co-authors of Mingyan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Mingyan Xu. A scholar is included among the top collaborators of Mingyan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingyan Xu. Mingyan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Feixiang, Mingyan Xu, Fan Liu, et al.. (2025). Single-cell RNA-seq combined with bulk RNA-seq analysis identifies necroptosis-related genes as therapeutic targets for periodontitis. BMC Medical Genomics. 18(1). 159–159. 1 indexed citations
2.
Guo, Wei, Yunlong Hu, Wei Wang, et al.. (2024). Assessment of plasma cell-free DNA fragmentation for multi-cancer early detection: An independent clinical validation study.. Journal of Clinical Oncology. 42(16_suppl). e15037–e15037. 1 indexed citations
3.
Li, Xianghui, Ying Wei, Mingyan Xu, et al.. (2024). A special electrostatic self-assembly structure of colloidal silica: Improving Chemical Mechanical Polishing performance. Materials Science in Semiconductor Processing. 173. 108169–108169. 3 indexed citations
4.
Yang, Zuoquan, Yanqing Zhou, Yaru Chen, et al.. (2024). Analytical and clinical validation of a personalized, tumor-informed circulating tumor DNA assay for minimal residual disease detection.. Journal of Clinical Oncology. 42(16_suppl). e14545–e14545.
5.
Xu, Mingyan, Xuemei Lu, Feixiang Zhu, et al.. (2024). BRG1 mediates epigenetic regulation of TNFα‐induced CCL2 expression in oral tongue squamous cell carcinoma cells. Journal of Cellular Biochemistry. 125(4). e30535–e30535. 3 indexed citations
6.
Shi, Wenxing, et al.. (2024). Ground penetrating radar urban road underground target classification algorithm using sequential spectral and time-domain features. Journal of Physics Conference Series. 2887(1). 12011–12011.
7.
Chen, Shifu, Yaru Chen, Wenjian Qin, et al.. (2023). Efficient sequencing data compression and FPGA acceleration based on a two-step framework. Frontiers in Genetics. 14. 1260531–1260531. 5 indexed citations
8.
Xu, Mingyan, Feixiang Zhu, Hao Yin, et al.. (2023). Serum Response Factor-Regulated IDO1/Kyn-Ahr Pathway Promotes Tumorigenesis of Oral Squamous Cell Carcinoma. Cancers. 15(4). 1319–1319. 8 indexed citations
9.
Xu, Mingyan, Junling Zhang, Xuemei Lu, et al.. (2023). MiR-199a-5p-Regulated SMARCA4 Promotes Oral Squamous Cell Carcinoma Tumorigenesis. International Journal of Molecular Sciences. 24(5). 4756–4756. 10 indexed citations
10.
Xu, Mingyan, Jie Huang, Feixiang Zhu, et al.. (2022). FOXO1 inhibits FSL-1 regulation of integrin β6 by blocking STAT3 binding to the integrin β6 gene promoter. Frontiers in Cellular and Infection Microbiology. 12. 998693–998693. 3 indexed citations
11.
He, Yayi, Linsong Chen, Lishu Zhao, et al.. (2021). Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLC. Theranostics. 11(14). 7092–7109. 11 indexed citations
12.
Guo, Shaohua, et al.. (2021). Intra-Tumor Heterogeneity of Colorectal Cancer Necessitates the Multi-Regional Sequencing for Comprehensive Mutational Profiling. Cancer Management and Research. Volume 13. 9209–9223. 4 indexed citations
13.
Liu, Guifeng, Ying Bao, Xi Zhang, et al.. (2021). Prognostic Factors of Colorectal Cancer: A Comparative Study on Patients With or Without Liver Metastasis. Frontiers in Oncology. 11. 626190–626190. 7 indexed citations
14.
Li, Yongguo, K. Zhang, Xi Zhang, et al.. (2019). Cancer Stem Cells of Diffuse Large B Cell Lymphoma Are Not Enriched in the CD45+CD19- cells but in the ALDHhigh Cells. Journal of Cancer. 11(1). 142–152. 10 indexed citations
15.
Li, Jun, Renzhong Liu, Cuihong Huang, Shifu Chen, & Mingyan Xu. (2018). The Introduction and Clinical Application of Cell-Free Tumor DNA. Methods in molecular biology. 1754. 45–65. 2 indexed citations
16.
Chen, Shifu, Tanxiao Huang, Tiexiang Wen, et al.. (2018). MutScan: fast detection and visualization of target mutations by scanning FASTQ data. BMC Bioinformatics. 19(1). 16–16. 11 indexed citations
17.
Chen, Shifu, Ming Liu, Xiaoni Zhang, et al.. (2017). A Study of Cell-Free DNA Fragmentation Pattern and Its Application in DNA Sample Type Classification. IEEE/ACM Transactions on Computational Biology and Bioinformatics. 15(5). 1718–1722. 4 indexed citations
18.
He, Wenjing, et al.. (2013). Inpatients' Knowledge about Primary Liver Cancer and Hepatitis. Asian Pacific Journal of Cancer Prevention. 14(8). 4913–4918. 10 indexed citations
19.
Deng, Xiaoling, Mingyan Xu, Chao Yuan, et al.. (2013). Transcriptional regulation of increased CCL2 expression in pulmonary fibrosis involves nuclear factor-κB and activator protein-1. The International Journal of Biochemistry & Cell Biology. 45(7). 1366–1376. 58 indexed citations
20.
Xu, Mingyan. (2004). Production of a human single-chain variable fragment antibody against esophageal carcinoma. World Journal of Gastroenterology. 10(18). 2619–2619. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026